Miller DP - Search Results

1

Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS.

Gong MN, Wei Z, Xu LL, Miller DP, Thompson BT, Christiani DC. Gong MN, et al. Among authors: miller dp. Chest. 2004 Jan;125(1):203-11. doi: 10.1378/chest.125.1.203. Chest. 2004. PMID: 14718442

2

Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.

Miller DP, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, Christiani DC. Miller DP, et al. Cancer Res. 2002 May 15;62(10):2819-23. Cancer Res. 2002. PMID: 12019159

3

Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.

Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, Su L, Christiani DC. Xu LL, et al. Among authors: miller dp. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1555-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496043

4

No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk.

Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S, Lynch TJ, Wain JC, Christiani DC. Su L, et al. Among authors: miller dp. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):174-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582031 Clinical Trial. No abstract available.

5

Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.

Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC. Miller DP, et al. Int J Cancer. 2003 May 10;104(6):758-63. doi: 10.1002/ijc.10989. Int J Cancer. 2003. PMID: 12640684

6

Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: miller dp. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692111

7

Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms.

Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Miller DP, et al. Epidemiology. 2003 Sep;14(5):545-51. doi: 10.1097/01.ede.0000073120.46981.24. Epidemiology. 2003. PMID: 14501269

8

MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinoma.

Liu G, Zhou W, Wang LI, Park S, Miller DP, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: miller dp. Cancer Lett. 2004 Oct 8;214(1):69-79. doi: 10.1016/j.canlet.2004.06.027. Cancer Lett. 2004. PMID: 15331175

9

The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.

Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Liu G, et al. Among authors: miller dp. Cancer. 2004 Dec 15;101(12):2802-8. doi: 10.1002/cncr.20716. Cancer. 2004. PMID: 15534883 Free article.

10

An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma.

Miller DP, Asomaning K, Liu G, Wain JC, Lynch TJ, Neuberg D, Su L, Christiani DC. Miller DP, et al. Cancer. 2006 Oct 1;107(7):1570-7. doi: 10.1002/cncr.22124. Cancer. 2006. PMID: 16933328 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters